Yue, Liang https://orcid.org/0000-0001-6478-7306
Jiang, Wenhao https://orcid.org/0009-0000-9381-9848
Li, Sainan
Luo, Meng
Fan, Ning
Zhan, Xiaolu
Sun, Rui https://orcid.org/0000-0002-8484-8089
Cheng, Honghan
Xue, Zhangzhi
Liu, Tong https://orcid.org/0000-0001-9234-1328
Zhou, Qianhe
Chen, Kexin
Lu, Tian
Guo, Fang
Li, Dongwei
Ge, Weigang
Nie, Zongxiang
Lyu, Mengge
A, Jun
Wang, Yingrui https://orcid.org/0000-0001-5532-3454
Chen, Yingdan
Fu, Zhenhai
Xiang, Nan
Li, Lu
Yu, Fengchao https://orcid.org/0000-0002-7695-3698
Teo, Guo Ci
Nesvizhskii, Alexey I. https://orcid.org/0000-0002-2806-7819
Wang, Meng https://orcid.org/0000-0001-5672-1411
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
Collins, Ben C. https://orcid.org/0000-0003-0827-3495
Xiao, Qi
Aebersold, Ruedi https://orcid.org/0000-0002-9576-3267
Xu, Fei
Yang, Hui https://orcid.org/0000-0002-2865-5311
Zhang, Sijia
Han, Yi
Zhu, Yi https://orcid.org/0000-0003-0429-0802
Ji, Yong https://orcid.org/0000-0003-2650-5747
Li, Yan https://orcid.org/0000-0002-5158-1816
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
Article History
Received: 23 November 2024
Accepted: 14 May 2026
First Online: 17 June 2026
Change Date: 19 June 2026
Change Type: Update
Change Details: In the HTML version of this article initially published, the Fig. 1 image was a duplicate of Fig. 4; Fig. 1 is now updated in the HTML version of the article.
Competing interests
: T.G. and Y.Z. are shareholders of Westlake Omics. A.I.N. is the founder of Fragmatics and serves on the scientific advisory boards of Protai Bio and Infinitopes. F.Y. is a paid consultant for Fragmatics. A.I.N. and F.Y. have financial conflicts of interest owing to the licensing of MSFragger and IonQuant to commercial entities. The data acquisition was partly supported by Bruker. The remaining authors declare no competing interests.